Latest Articles about OMCL

Covance Beats Earnings, Rev, Ups View - Analyst Blog

Zacks Equity Research — Mon, 06 May 2013 17:15:01 Z

Covance Inc. ( CVD ) reported adjusted earnings per share of 75 cents in the first quarter of 2013, beating the year-ago results by 25% and the Zacks Consensus Estimate by 4.2%.

Dismal Earnings Miss by Omnicell - Analyst Blog

Zacks Equity Research — Fri, 03 May 2013 16:33:07 Z

Omnicell Inc. ( OMCL ) reported first-quarter 2013 net operating earnings of 14 cents per share, missing the Zacks Consensus Estimate of 19 cents. Results nevertheless improved 7.7% year

Still Neutral on Omnicell - Analyst Blog

Zacks Equity Research — Sat, 23 Mar 2013 00:26:55 Z

On Mar 19, 2013, we reiterated our Neutral recommendation on Omnicell Inc ( OMCL ) following its fourth-quarter results. The stock also carries a Zacks Rank #3 (Hold). Why the

Omnicell Beats with Record Numbers - Analyst Blog

Zacks Equity Research — Fri, 01 Feb 2013 22:40:01 Z

Provider of automation solutions for the medication-use process, Omnicell Inc. ( OMCL ) reported earnings per share (EPS) of 16 cents in the fourth quarter of 2012, significantly up from 12

Omnicell Gains Foothold in Qatar - Analyst Blog

Zacks Equity Research — Wed, 30 Jan 2013 01:00:01 Z

Omnicell Inc. ( OMCL ), provider of end-to-end automation solutions for medication-use process, continues to expand its client base. The company along with its partner Mannai Corporation

Omnicell in Arab Health Conference - Analyst Blog

Zacks Equity Research — Tue, 29 Jan 2013 00:40:01 Z

Omnicell Inc. ( OMCL ), a provider of end-to-end automated solutions for medication-use process, recently revealed that it will showcase its highly regarded G4 know-how as well as other

Omnicell Widens Customer Base - Analyst Blog

Zacks Equity Research — Thu, 17 Jan 2013 00:40:01 Z

Omnicell Inc. ( OMCL ), provider of end-to-end automated solutions for medication-use process, has expanded its customer base as Springhill Medical Center selected it as its exclusive

Omnicell Pinned at Neutral - Analyst Blog

Zacks Equity Research — Tue, 01 Jan 2013 01:00:01 Z

Following a strong third-quarter result, we have reiterated our long-term 'Neutral' recommendation on Omnicell ( OMCL ), provider of end-to-end automation solutions for the medication-use

SNN Extends Legion Knee System - Analyst Blog

Zacks Equity Research — Wed, 26 Dec 2012 20:50:01 Z

Orthopedic major Smith & Nephew ( SNN ) recently extended its well-regarded Legion Total Knee System with Legion Narrow Femoral Components containing Oxinium Oxidized Zirconium.

Omnicell Inc. - Aggressive Growth

Zacks Equity Research — Fri, 02 Nov 2012 09:00:01 Z

Earnings momentum for Omnicell Inc. ( OMCL ) has jumped in the past 7 days, since this provider of end-to-end automation solutions released strong third quarter results last week. Shares of

OMCL Beats on EPS, Margins Expand - Analyst Blog

Zacks Equity Research — Tue, 30 Oct 2012 18:26:10 Z

Omnicell Inc. ( OMCL ) reported earnings per share (EPS) of 20 cents in the third quarter of fiscal 2012, significantly up from the year-ago quarter EPS of 9 cents. However, excluding the

CareFusion Awards Best Hospitals - Analyst Blog

Zacks Equity Research — Tue, 11 Sep 2012 22:30:01 Z

Medical technology company CareFusion ( CFN ) recently revealed that it recognized 1,187 U.S.-based hospitals for winning a minimum of one out of four awards conferred to the country's

Product Recall Woes for CareFusion - Analyst Blog

Zacks Equity Research — Sat, 25 Aug 2012 01:33:42 Z

Recently, CareFusion ( CFN ), a medical technology company, announced the voluntary recall of its Alaris Pump Module, Model 8100. The recalled lot was manufactured between October 2011 and

Omnicell Reiterated at Neutral - Analyst Blog

Zacks Equity Research — Thu, 16 Aug 2012 00:20:01 Z

We have reiterated our Neutral recommendation on Omnicell ( OMCL ) with a target price of $15.00. Omnicell reported EPS of 4 cents in the second quarter of fiscal 2012, lower than the

OMCL Beats on Revs, Drag on Margins - Analyst Blog

Zacks Equity Research — Thu, 02 Aug 2012 21:20:38 Z

Omnicell Inc. ( OMCL ) reported EPS of 4 cents in the second quarter of fiscal 2012, lower than the year-ago quarter EPS of 8 cents. The Zacks Consensus EPS for the second quarter 2012 was 6